Nord Surgery - Company finances
|
EUR
|
2018
From: 2018-03-28
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 18,400 | 39,000 | 38,200 | 34,173 | 42,000 | 30,965 | 42,000 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -29,360 | -24,075 | 118 | 23,751 | 9,830 | 9,072 | 9,256 | 11,268 |
| Equity | -26,860 | -50,935 | -50,817 | -27,066 | -17,236 | 10,864 | 20,120 | 31,387 |
| Liabilities | 88,035 | 110,557 | 109,324 | 88,747 | 510,234 | 679,943 | 1,432,712 | 2,466,957 |
| Non-current assets | 59,310 | 54,483 | 52,310 | 30,138 | 27,965 | 567,683 | 1,184,944 | 2,200,620 |
| Current assets | 1,865 | 5,139 | 6,197 | 31,543 | 403,998 | 65,664 | 159,757 | 217,904 |
| Total assets | 61,175 | 59,622 | 58,507 | 61,681 | 431,963 | 633,347 | 1,344,701 | 2,418,524 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 7,535 | 7,806 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +112.0% | -2.1% | -10.5% | +22.9% | -26.3% | +35.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -48.0% | -40.4% | 0.2% | 38.5% | 2.3% | 1.4% | 0.7% | 0.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | 83.5% | 46.0% | 35.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -130.8% | 0.3% | 62.2% | 28.8% | 21.6% | 29.9% | 26.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | 62.6 | 71.2 | 78.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 18,400 | 39,000 | 38,200 | 17,829 | 21,000 | 15,483 | 16,800 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Nord Surgery - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-05-16 | 2025-05-18 | 0.59 |
| 2025-05-04 | 2025-05-07 | 0.59 |
| 2025-04-24 | 2025-04-29 | 0.59 |
| 2025-02-18 | 2025-02-20 | 543.29 |
Nord Surgery - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Nord Surgery, UAB (company code 304813470) is a Private Limited Liability Company engaged in business and other management consultancy activities. In 2025, the company generated revenue of €42.0K and net profit of €11.3K, giving a profit margin of 26.8%. Revenue increased by 35.6% year on year, recovering from €31.0K in 2024 after €42.0K in 2023. Profitability has been positive across the period, with net profit rising from €9.1K in 2023 to €9.3K in 2024 and €11.3K in 2025. The balance sheet expanded significantly, with total assets of €2.42M and liabilities of €2.47M at the end of 2025. Equity remained modest at €31.4K, resulting in an equity ratio of 1.3% and a high debt-to-equity ratio of 78.60. Return on equity was 35.9%, while return on assets was 0.5%, reflecting the company’s large asset base relative to earnings. Asset turnover was 0.02x. With revenue per employee of €21.0K and profit per employee of €5.6K, the company operated with limited turnover but maintained positive earnings in 2025.